Loading institutional data...
Loading institutional data...
Held by 3,014 of 5,944 reporting institutions (100th percentile) — extremely crowded.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
How management deployed cash over 10 years — and what it earned on reinvestment.
A cash-return story — far more went to shareholders than back into the business (mature, low-reinvestment).
Operating income fell despite reinvestment — a warning on capital productivity. Current ROIC on all capital: 12%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Cash of $9.1B covers the $4.6B due within a year 2.0× over. Scheduled principal only (excludes interest & revolver draws). As of 2025-12-31 (10-K).
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Coverage is adequate but not comfortable. Effective rate ~5.0% on $54.6B of debt.
Cash of $9.1B fully covers short-term debt of $4.6B.
Mostly long-term debt (balance-sheet current vs non-current split). See the maturity ladder above for the year-by-year repayment schedule.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
Solve the discounted cash flow backwards, then stress-test the assumptions.
To be worth $379.78 today, the market must believe free cash flow compounds 12.8%/yr for a decade (off $8.6B normalized FCF).
The market's 12.8% is more optimistic than its 9-yr track record.
2-stage DCF · 0.54B shares · net debt $45.5B
mean -0.1% · volatility σ 21% · implied rate exceeded in 2/9 yrs
Central path = implied 12.8%/yr growth; shaded band = ±1σ (21%) of this company's historical FCF volatility, widening with time. The wider the band, the less certain the growth.
Reverse DCF: rather than guessing a fair value, we solve for the growth the current price implies, then you stress-test the assumptions. Enterprise value of the FCF stream, less net debt, ÷ shares. Educational — not a recommendation.
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
Insufficient balance-sheet detail (needs retained earnings, working capital, equity).
Eight indices comparing this year to last (receivables, margins, asset quality, growth, accruals, leverage). Above −1.78 suggests possible manipulation; below −2.22 is clean.
A screen, not proof — high growth alone can raise it.
Earnings are backed by cash (FCF ≥ net income) — high quality. Lower/negative accruals = higher quality (Sloan).
Interest coverage is thin — monitor; leverage falling year-over-year.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
The dividend is comfortably covered — only 63% of free cash flow, leaving room to grow it and fund buybacks. Last year: $5.1B dividends + $0 buybacks = $5.1B returned on $8.1B FCF.
9 consecutive years of dividend increases · 10%/yr.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
EOD close · as of 2026-09-17
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $36.75B 100.0% | $33.42B 100.0% | $28.19B 100.0% | $26.32B 100.0% | $25.98B 100.0% | $25.42B 100.0% | $23.36B 100.0% | $23.75B 100.0% | $22.85B 100.0% | $22.99B 100.0% |
| Cost of Revenue | $12.04B 32.8% | $12.86B 38.5% | $8.45B 30.0% | $6.41B 24.3% | $6.45B 24.8% | $6.16B 24.2% | $4.36B 18.6% | $4.10B 17.3% | $4.07B 17.8% | $4.16B 18.1% |
| Cost of Products | — | — | — | — | — | — | — | — | $4.07B 17.8% | $4.16B 18.1% |
| Selling, General & Admin | $7.05B 19.2% | $7.10B 21.2% | $6.18B 21.9% | $5.41B 20.6% | $5.37B 20.7% | $5.73B 22.5% | $5.15B 22.0% | $5.33B 22.5% | $4.87B 21.3% | $5.06B 22.0% |
| Total Operating Expenses | $27.67B 75.3% | $26.17B 78.3% | $20.29B 72.0% | $16.76B 63.7% | $18.34B 70.6% | $16.29B 64.1% | $13.69B 58.6% | $13.48B 56.8% | $12.88B 56.4% | $13.20B 57.4% |
| Operating Income | $9.08B 24.7% | $7.26B 21.7% | $7.90B 28.0% | $9.57B 36.3% | $7.64B 29.4% | $9.14B 35.9% | $9.67B 41.4% | $10.26B 43.2% | $9.97B 43.6% | $9.79B 42.6% |
| Interest Expense | $2.75B 7.5% | $3.15B 9.4% | $2.88B 10.2% | $1.41B 5.3% | $1.20B 4.6% | $1.26B 5.0% | $1.29B 5.5% | $1.39B 5.9% | $1.30B 5.7% | $1.26B 5.5% |
| Interest & Investment Income | $408.0M 1.1% | $510.0M 1.5% | $1.20B 4.3% | $127.0M 0.5% | $11.0M 0.0% | — | — | — | — | — |
| Other Income (Expense), net | $2.65B 7.2% | $506.0M 1.5% | $2.83B 10.0% | -$814.0M -3.1% | $259.0M 1.0% | $256.0M 1.0% | $753.0M 3.2% | $674.0M 2.8% | $928.0M 4.1% | $629.0M 2.7% |
| Pretax Income | $8.98B 24.4% | $4.61B 13.8% | $7.86B 27.9% | $7.35B 27.9% | $6.70B 25.8% | $8.13B 32.0% | $9.14B 39.1% | $9.54B 40.2% | $9.60B 42.0% | $9.16B 39.9% |
| Income Tax Expense | $1.26B 3.4% | $519.0M 1.6% | $1.14B 4.0% | $794.0M 3.0% | $808.0M 3.1% | $869.0M 3.4% | $1.30B 5.5% | $1.15B 4.8% | $7.62B 33.3% | $1.44B 6.3% |
| Net Income | $7.71B 21.0% | $4.09B 12.2% | $6.72B 23.8% | $6.55B 24.9% | $5.89B 22.7% | $7.26B 28.6% | $7.84B 33.6% | $8.39B 35.3% | $1.98B 8.7% | $7.72B 33.6% |
| Per Share | ||||||||||
| EPS (Basic) | $14.33 | $7.62 | $12.56 | $12.18 | $10.34 | $12.40 | $12.96 | $12.70 | $2.71 | $10.32 |
| EPS (Diluted) | $14.23 | $7.56 | $12.49 | $12.11 | $10.28 | $12.31 | $12.88 | $12.62 | $2.69 | $10.24 |
| Weighted Avg Shares (Basic) | 538.0M | 537.0M | 535.0M | 538.0M | 570.0M | 586.0M | 605.0M | 661.0M | 731.0M | 748.0M |
| Weighted Avg Shares (Diluted) | 542.0M | 541.0M | 538.0M | 541.0M | 573.0M | 590.0M | 609.0M | 665.0M | 735.0M | 754.0M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
Ranked against 1085 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-03-31.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| BCAX | $1.24T | — | — | — | — | — | — | -34.4% | -34.4% | — | 143 |
| LLY | $1.03T | 50.2× | — | 15.9× | 44.7% | 83.0% | 31.7% | 77.8% | 29.9% | — | 4,193 |
| AKTX | $894.1B | — | — | — | — | — | — | -61.1% | -61.1% | — | 1 |
| JNJ | $650.5B | 24.5× | — | 6.9× | 6.0% | 67.9% | 28.5% | 32.9% | 20.7% | — | 4,451 |
| ABBV | $467.1B | 111.9× | 33.4× | 7.6× | 8.6% | 70.2% | 6.9% | -129% | 6.6% | 4.2× | 3,895 |
| MRK | $368.2B | 20.2× | — | 5.7× | 1.3% | 74.8% | 28.1% | 34.7% | 17.9% | — | 3,594 |
| UNH | $339.9B | 28.4× | 19.7× | 0.8× | 11.8% | 88.7% | 2.7% | 12.0% | 6.8% | 3.9× | 2,891 |
| AZN | $257.7B | — | — | — | — | — | — | — | — | — | 1,248 |
| TMO | $248.2B | 37.1× | 31.9× | 5.6× | 3.9% | — | 15.0% | 12.6% | 7.0% | 4.9× | 2,481 |
| AMGN | $204.6B | 26.7× | 17.6× | 5.6× | 10.0% | 67.2% | 21.0% | 89.1% | 12.2% | 3.8× | 3,014 |
| GILD | $187.3B | 22.3× | 20.4× | 6.4× | 2.4% | 78.8% | 28.9% | 37.5% | 17.9% | 2.4× | 2,218 |
| ABT | $178.0B | 27.5× | 19.2× | 4.0× | 5.7% | 56.4% | 14.7% | 12.5% | 10.0% | 1.4× | 2,964 |
| PFE | $157.1B | 20.3× | — | 2.5× | -1.6% | 74.3% | 12.4% | 9.0% | 5.1% | — | 2,838 |
| DHR | $150.2B | 42.1× | 31.0× | 6.1× | 2.9% | 59.1% | 14.7% | 6.9% | 5.1% | 3.4× | 2,083 |
| ISRG | $136.2B | 48.7× | 37.5× | 13.5× | 20.5% | 66.0% | 28.4% | 16.0% | 16.0% | — | 2,190 |
| VRTX | $131.1B | 33.7× | 28.8× | 10.9× | 8.9% | 86.2% | 32.9% | 21.2% | 21.2% | — | 1,609 |
| BMY | $127.8B | 18.2× | — | 2.6× | -0.2% | 71.1% | 14.6% | 38.2% | 11.1% | — | 2,431 |
| MDT | $118.8B | 24.9× | 12.6× | 3.3× | 8.4% | 65.0% | 13.2% | 9.7% | 9.4% | 0.2× | 2,114 |
| CVS | $114.7B | 64.9× | 11.5× | 0.3× | 7.8% | 45.0% | 0.4% | 2.4% | 2.4% | 0.0× | 1,795 |
| SYK | $107.1B | 33.4× | 18.4× | 4.3× | 11.2% | 64.0% | 12.9% | 14.5% | 8.5% | 2.5× | 2,196 |
| MCK | $102.5B | 22.9× | 16.2× | 0.3× | 12.4% | 3.6% | 1.2% | -219% | 109% | 1.0× | 1,946 |
| HCA | $96.4B | 15.1× | — | 1.3× | 7.1% | — | 9.0% | -113% | 16.8% | — | 1,346 |
| ELV | $91.4B | 16.4× | 15.5× | 0.5× | 12.5% | 89.4% | 2.8% | 12.9% | 7.6% | 4.2× | 1,397 |
| REGN | $82.6B | 19.0× | 19.8× | 5.8× | 1.0% | — | 31.4% | 14.4% | 13.6% | 0.5× | 1,336 |
| CI | $72.7B | 12.4× | 5.5× | 0.3× | 11.2% | 21.8% | 2.2% | 14.3% | 14.1% | 0.0× | 1,583 |
Peers = companies sharing AMGN's sector (Healthcare) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.
EOD close · as of 2026-09-17
Where each multiple sits in its own 14-yr range · 95th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 14-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
Watch the leverage lever — a chunk of ROE comes from the balance sheet.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
High operating leverage: profit moved 2.5× as fast as sales — great in an upturn, painful in a downturn.
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 17.3 | 18.6 | 24.2 | 24.8 | 24.3 | 30.0 | 38.5 | 32.8 |
| SG&A | 22.5 | 22.0 | 22.5 | 20.7 | 20.6 | 21.9 | 21.2 | 19.2 |
| Operating Income | 43.2 | 41.4 | 35.9 | 29.4 | 36.3 | 28.0 | 21.7 | 24.7 |
| Income Tax | 4.8 | 5.5 | 3.4 | 3.1 | 3.0 | 4.0 | 1.6 | 3.4 |
| Net Income | 35.3 | 33.6 | 28.6 | 22.7 | 24.9 | 23.8 | 12.2 | 21.0 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on AMGN: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.